SCHEMBL7441069

SCHEMBL7441069

[CH2]c1nc(-c2nc3ccccc3[nH]2)cs1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 14/20 0.69
RAB9A P51151 14/20 0.69
SMN1; SMN2 Q16637 11/20 0.69
TP53 P04637 7/20 0.69
ALOX15 P16050 3/20 0.69
FKBP1A P62942 2/20 0.69
KDM4E B2RXH2 11/20 0.56
METAP2 P50579 3/20 0.56
CYP3A4 P08684 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
TSHR P16473 2/20 0.56
METAP1 P53582 2/20 0.56
ADORA3 P0DMS8 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C19 P33261 1/20 0.56
HIF1A Q16665 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
ALDH1A1 P00352 11/20 0.56
HSD17B10 Q99714 7/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3140719 0.82 RAB9A (1.00) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL28427886 0.81 NPC1 (0.69) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL11858858 0.81 NPC1 (0.69) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL9457146 0.81 NPC1 (0.69) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL32665693 0.78 KDM4E (0.78) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL32665695 0.77 KDM4E (0.76) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL5879554 0.77 SMN1; SMN2 (0.68) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL32665696 0.77 KDM4E (0.76) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL172216 0.74 NPC1 (1.00) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL30561047 0.74 NPC1 (1.00) NPC1RAB9ASMN1; SMN2TP53ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202988-A2 NOVEL INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2002-05-08 EP disclosed
WO-2001010847-A2 NOVEL INTEGRIN RECEPTOR ANTAGONISTS BASF AKTIENGESELLSCHAFT (DE) 2001-02-15 WO disclosed